Ligand Pharmaceuticals Incorporated (LGND) financial statements (2021 and earlier)

Company profile

Business Address 3911 SORRENTO VALLEY BLVD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4111,012718202141200
Cash and cash equivalents4872117211997
Short-term investments364940601181122103
Restricted cash and investments 1    
Receivables59425626156
Inventory, net of allowances, customer advances and progress billings2677422
Inventory2677422
Derivative instruments and hedges, assets  23   
Other current assets4520222
Other undisclosed current assets 5846435
Total current assets:5011,124871237163215
Noncurrent Assets
Finance lease, right-of-use asset16 
Operating lease, right-of-use asset710
Property, plant and equipment1475420
Long-term investments and receivables   6830
Long-term investments   6830
Intangible assets, net (including goodwill)78530630631527761
Goodwill1909587867212
Intangible assets, net (excluding goodwill)59521022022920548
Deferred income tax assets2426
Other noncurrent assets420520
Deferred tax assets, net  124189
Other undisclosed noncurrent assets112078104269
Total noncurrent assets:862371390434439288
TOTAL ASSETS:1,3621,4951,261671602503
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2212231099
Accounts payable424234
Accrued liabilities191019765
Deferred revenue292
Debt7126225213202
Derivative instruments and hedges, liabilities  23   
Contract with customer, liability3
Other liabilities     0
Other undisclosed current liabilities42165511
Total current liabilities:1001782239227223
Noncurrent Liabilities
Long-term debt and lease obligation448649610   
Long-term debt, excluding current maturities442639610   
Finance lease, liability0 
Operating lease, liability610
Liabilities, other than long-term debt95551410
Deferred revenue and credits4  
Deferred income tax liabilities6533
Other liabilities31221110
Other undisclosed noncurrent liabilities967933
Total noncurrent liabilities:5537116181443
Total liabilities:653728700252231226
Stockholders' equity
Stockholders' equity attributable to parent710767561400341237
Common stock000000
Additional paid in capital318367791798770662
Accumulated other comprehensive income (loss)(1)(0)(1)235
Retained earnings (accumulated deficit)392400(229)(401)(431)(429)
Total stockholders' equity:710767561400341237
Other undisclosed liabilities and equity   193040
TOTAL LIABILITIES AND EQUITY:1,3621,4951,261671602503

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues18612025114110972
Revenue, net1118266
Cost of revenue
(Cost of Goods and Services Sold)
(23)(17)(6)(12)(6)(1)
Gross profit:16310324512910371
Operating expenses(178)(126)(88)(73)(65)(45)
Other undisclosed operating income4183061261
Operating income:26807164684427
Nonoperating income (expense)(36)(10)10(11)(36)8
Investment income, nonoperating(9)3114  28
Other nonoperating income (expense)(0)(6)(6)532
Interest and debt expense(27)(36)(48)   
Other undisclosed income from continuing operations before equity method investments, income taxes273648   
Income (loss) from continuing operations before equity method investments, income taxes:(11)79717357835
Income from equity method investments 3    
Income (loss) from continuing operations before income taxes:(11)80017357835
Income tax expense (benefit)8(167)(30)(45)(10)192
Income (loss) from continuing operations:(3)63214313(2)227
Income from discontinued operations    1 
Income (loss) before gain (loss) on sale of properties:(3)63214313(2)227
Other undisclosed net loss (3)    
Net income (loss):(3)62914313(2)227
Net income attributable to noncontrolling interest     2
Net income (loss) available to common stockholders, diluted:(3)62914313(2)230

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(3)62914313(2)227
Other comprehensive income (loss)  0(0)(2) 
Comprehensive income (loss):(3)62914312(4)227
Comprehensive income, net of tax, attributable to noncontrolling interest     2
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)1(1)  (0)
Comprehensive income (loss), net of tax, attributable to parent:(4)63014212(4)230

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: